Additionally, it reduced p16 and p21 expression in dorsal root ganglia cells cultured from a cisplatin-induced model of peripheral neuropathy in vitro and improved neuronal functional response to pain in vivo [54] (Table 1). The gene discussed is CDKN2A; the disease is peripheral neuropathy.